Cited by 162Diabetes, Cardiovascular Risks, and LipoproteinsDiet, Metabolism, and DiseasePancreatic function and diabetes

Decreased Susceptibility to Fatty Acid–Induced Peripheral Tissue Insulin Resistance in Women

Open access
Frias, Juan P., Macaraeg, Gina B., Ofrecio, Jachelle, Yu, Joseph G., Olefsky, Jerrold M., Kruszynska, Yolanta T.·2001·Diabetes

Abstract

Elevation of plasma nonesterified fatty acid (NEFA) levels has been shown in various studies to induce peripheral tissue insulin resistance and impair the suppression of endogenous glucose production (EGP). These studies have been conducted predominantly in men. We compared the effects of elevated plasma NEFA levels on basal and insulin-stimulated glucose metabolism in 8 normal women (age 42 ± 8 years [mean ± SD], BMI 25 ± 3 kg/m2) and 10 normal men (35 ± 6 years, 24 ± 3 kg/m2). Each subject underwent two 5-h 80 mU · m–2 · min–1 hyperinsulinemic-euglycemic clamps with measurement of glucose kinetics (intravenous [3-3H]glucose) and substrate oxidation. Plasma NEFA levels were elevated in one study for 3 h before and during the clamp (∼1 mmol/l in both groups) by infusion of 20% Intralipid (60 ml/h) and heparin (900 U/h). In the control studies, the men and women had similar insulin-stimulated glucose disposal rates (Rd) and substrate oxidation rates. In the men, elevated NEFA levels decreased insulin-stimulated glucose Rd during the final 40 min of the clamp by 23% (P < 0.001). By contrast, no significant change in glucose Rd was found in the women (control 10.4 ± 1.1, lipid study 9.9 ± 1.3 mg · kg–1 · min–1). Glucose Rd was also unchanged in six women studied at a lower insulin dose (40 mU · m–2 · min–1). During the last 40 min of the high–insulin dose clamps with elevated NEFA, glucose oxidation was decreased by 33% in the men (P < 0.001) and by 23% in the women (P < 0.02). Nonoxidative glucose Rd at this time was decreased by 15% in the men (P = 0.02) but was not significantly affected in women. Basal EGP was unaffected by elevation of plasma NEFA levels in both groups. Suppression of EGP during the glucose clamps, however, was impaired. At the insulin infusion rate used, the magnitude of this defect was comparable in men and women. In summary, our findings suggest that although the effects on EGP appear comparable, the inhibitory effects of NEFA on peripheral tissue insulin sensitivity are observed in men but cannot be demonstrated in women.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/diabetes.50.6.1344

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Women are resistant to FFA-induced insulin resistance.

    “In fact, women are resistant to FFA-induced insulin resistance [34].”

    From Sex differences in metabolic homeostasis, diabetes, and obesity (2015) · cites this paper as [34]

    The Discussion reports that elevated fatty acids did not impair insulin-stimulated peripheral glucose uptake in the women studied, unlike in men. But it also reports impaired suppression of endogenous glucose production in women, so the unqualified claim that women are resistant to FFA-induced insulin resistance is broader than the finding. (LLM, conf=0.88)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 42 · Cited by 162

Authors
Frias, J. P., Macaraeg, G. B., Ofrecio, J., Yu, J. G., Olefsky, J. M., & Kruszynska, Y. T.
Affiliations
  • Department of Endocrinology and Metabolism, University of California–San Diego, Veterans Affairs Medical Center, La Jolla, California
  • University of California San Diego (US)
Venue
Diabetes
Published
2001-06-01
Volume
50
Issue
6
Pages
1344-1350
ISSN
  • 0012-1797 (ISSN-L)
  • 1939-327X
OpenAlex
W2125528261
Cited by
162
References
42
Citations by year
2026: 4 · 2025: 6 · 2024: 11 · 2023: 13 · 2022: 7 · 2021: 6 · 2020: 9 · 2019: 10 · 2018: 8 · 2017: 8 · 2016: 7 · 2015: 6 · 2014: 6 · 2013: 7 · 2012: 5
FWCI
3.85
Type
journal article
Language
en
Open access
Locations
  • Diabetes (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health
  • National Institute of Diabetes and Digestive and Kidney Diseases (DK-33649)
  • National Center for Research Resources (M-01RR00827, M01RR000827)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
  • Health Sciences › Medicine › Surgery › Pancreatic function and diabetes
Keywords
insulin resistance, free fatty acids, fatty acid infusion, sex differences, women, peripheral glucose metabolism, insulin-stimulated glucose disposal, substrate oxidation, glucose oxidation, nonoxidative glucose disposal, endogenous glucose production, hyperinsulinemic-euglycemic clamp, Intralipid, glucose kinetics, insulin sensitivity
MeSH terms
Adult, Blood Glucose, Drug Resistance, Fatty Acids, Fatty Acids, Nonesterified, Female, Glucose, Humans, Insulin, Insulin Resistance, Male, Middle Aged, Osmolar Concentration, Oxidation-Reduction, Sex Characteristics, Triglycerides, Glucose Clamp Technique

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review